MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. The company has two marketed products and an advancing pipeline of promising candidates, all designed to treat or prevent a number of debilitating or life-threatening diseases.

With ... More >>

Date Title   06/29/09 MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 06/29/09 MedImmune Expands Access for Eligible Premature Infants to Receive Synagis(R) at No Cost 06/01/09 HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1) 05/05/09 FluMist® Shows Acceptable Safety Profile in Immunocompromised Children, According to New Findings Presented at Pediatric Academic Societies Annual Meeting